Lyra Therapeutics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Lyra Therapeutics Inc
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company’s operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Lyra Therapeutics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Lyra Therapeutics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Lyra Therapeutics Inc is LYRA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Lyra Therapeutics Inc has its primary listing on NASDAQ. You can trade Lyra Therapeutics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Lyra Therapeutics Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Lyra Therapeutics Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Lyra Therapeutics Inc.